Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
E2F1 expression is deregulated and plays an oncogenic role in sporadic Burkitts lymphoma
Cureus 13(3):e14104 Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030
Available in 2 stacks save up to 91,00 Repair Matrix - Startsave 28,00 View the stack Repair Matrix - Advancedsave 91,00 View the stack BPC-157 - Recovery & Regeneration Research Peptide Promotes cellular migration and proliferation essential for structural repair in injured tissues Observed to accelerate healing kinetics in preclinical models of transected tendons and damaged ligaments Upregulates VEGFR2 activity, contributing to robust blood vessel formation (angiogenesis) for enhanced nutrient delivery Demonstrates powerful cytoprotective effects throughout the digestive tract in animal models of mucosal damage Studies show enhanced myogenesis and functional recovery in skeletal muscle injury models Observed to reduce inflammatory cytokines (e.g., IL-6, TNF-) following ischemic injury in preclinical research Research indicates support for bone healing, particularly in compromised conditions like avascular osteonecrosis May modulate central nervous system signaling, including dopamine and glutamate pathways, in rodent brain injury models Description BPC-157 is a synthetic peptide fragment derived from human gastric juice , composed of 15 amino acids and known for its broad regenerative and cytoprotective properties
Their clinical effects extend beyond weight loss, with evidence supporting their benefits on diabetes prevention, diabetes control, and improvement of cardiovascular disease and metabolic-associated steatotic liver disease (MASLD) outcomes
Serum biomarker patterns did not indicate an increased risk of thrombosis and were observed to normalise during garadacimab treatment
US$ 21.59
US$ 27.56
US$ 25.18
